Connect with us

Technology

Breakthrough Properties Joined by San Diego Mayor Todd Gloria to Celebrate the Opening of Torrey View By Breakthrough Development

Published

on

Fully Leased Life Science Campus is Now Home to Leading Companies
Including Pfizer and BD Biosciences

SAN DIEGO, Oct. 17, 2024 /PRNewswire/ — Breakthrough Properties was joined by San Diego Mayor Todd Gloria, UCSD Chancellor Pradeep Khosla, Ph.D. and representatives from Pfizer and BD Biosciences on September 30 to commemorate the opening of Torrey View, its newly-developed, 10-acre life science campus in Del Mar Heights.

Breakthrough successfully pre-leased the entire 520,000-square-foot campus to an impressive lineup of leading companies months prior to completion. The oncology division of biopharmaceutical company Pfizer leased 230,000 square feet spanning two buildings. Global medical technology company BD (Becton, Dickinson and Company) created a 220,000-square-foot innovation center for its Biosciences division across a third building. Charles River Laboratories, Actio Biosciences and Architect Therapeutics have also established a presence at the campus.

Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, acquired the Torrey View site in October 2020 and transformed it into a world-class research and development center, which has achieved USGBC LEED Gold certification.

“This world-class campus is a setting fit for some of the brightest minds in medicine, and will further strengthen the thriving innovation ecosystem that fuels groundbreaking discoveries,” said San Diego Mayor Todd Gloria. “I’m proud that top life-science companies continue to choose San Diego as their home, and I look forward to seeing the life-changing advancements that will come from this new facility.” 

“We are delighted to celebrate the completion of Torrey View alongside Mayor Gloria, UCSD Chancellor Dr. Pradeep Khosla and our many distinguished guests from San Diego’s vibrant life sciences community,” said Breakthrough CEO Dan Belldegrun.  “We developed Torrey View as a premier hub of innovation and collaboration where important research will be conducted and advanced.  We’re proud to welcome these cutting-edge companies to their new home.”

“Torrey View showcases Breakthrough’s ability to deliver the best real estate product for the best minds in life science,” said Tishman Speyer CEO Rob Speyer.  “The work happening within these walls will literally save lives and reshape healthcare.  I congratulate the Breakthrough team and thank our partners in the community for championing this project.”

“We’re proud to soon open the doors at our new site here in Torrey View, a site that will continue to enable world-class scientific innovation and the delivery of impactful new medicines to patients with cancer,” said Jeff Settleman, Ph.D., Chief Scientific Officer for Oncology Research and Development Pfizer La Jolla site head. “Over the past few years, Pfizer has made a significant investment in the oncology therapeutic space – this new state-of-the-art facility is a reflection of our commitment to both our colleagues and the patients we serve.”

“We need ecosystems like Torrey View to bring together the brightest minds, most innovative companies and forward-thinking entrepreneurs,” said UCSD Chancellor Pradeep Khosla, Ph.D.  “With the extensive premier life science space and amenities that Torrey View plans to offer, it is poised to become a hub for groundbreaking research, development and discovery. Academia needs strong partnerships to achieve maximum success.”

Breakthrough developed Torrey View alongside its co-equity partners Mitsui Fudosan America, Investment Management Corporation of Ontario (IMCO) and AP2. To realize its vision, Breakthrough collaborated with life science architectural firm Flad Architects and general contractor Clark Construction.  JLL exclusively handled the leasing program at the development.

The campus features expansive ocean views and a full suite of curated campus amenities, including a client clubhouse, multiple dining options, a Jay Wright-designed fitness center and pickleball court, a 400-person conference facility, robust bike and surfboard storage and onsite parking via a partially below grade garage covered by open green spaces and gardens.   

Breakthrough is one of the most active players in the sector with a portfolio that spans more than five million square feet of premier life science environments in operation and in the development pipeline across the United States and Europe. Breakthrough’s ongoing commitment to sustainability involves a particular emphasis on increasing energy efficiency, reducing carbon emissions and providing healthy workspaces for users, including targeting LEED Gold certification at its United States properties, as well as BREEAM Outstanding certification in all of its projects across the United Kingdom and EU markets.

In addition to Torrey View, Breakthrough’s San Diego portfolio encompasses Torrey Plaza, Callan Ridge and Governor Pointe, a two-story life science campus nearing completion.  Other portfolio highlights include The 105, a state-of-the-art facility fully leased by CRISPR Therapeutics, and One Milestone, two interconnected lab buildings under development at the Enterprise Research Campus, in Boston; 2300 Market, a research & development building nearing completion in Philadelphia; and Trinity, a bespoke lab and office project being developed in Oxford UK. In addition, StudioLabs by Breakthrough — curated, turn-key innovation environments for hypergrowth users — are being launched in several new markets.

About Breakthrough Properties

Formed in 2019 as a joint venture between global real estate owner, developer, and investor Tishman Speyer and biotechnology investment firm Bellco Capital, Breakthrough Properties is a life science real estate development company that leverages cross-sector collaboration to deliver environments that foster innovation and scientific breakthroughs. Breakthrough Properties’ mission is to acquire, develop and operate the best life science properties in leading urban technology centers around the world and support scientific innovation across biotechnology, agriculture, and nutrition. Breakthrough combines Tishman Speyer’s decades of global real estate development experience with Bellco Capital’s industry-making biotechnology entrepreneurship to reimagine environments where companies can create life-changing therapies for patients.

View original content to download multimedia:https://www.prnewswire.com/news-releases/breakthrough-properties-joined-by-san-diego-mayor-todd-gloria-to-celebrate-the-opening-of-torrey-view-by-breakthrough-development-302279810.html

SOURCE Breakthrough Properties

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Barrel Energy Inc. Announces Full SEC Reporting Status, Strengthening Marketability and Positioning Company for Expansion in Renewable and Nutritional Energy Markets

Published

on

By

Barrel Energy Inc. (OTC: BRLL) A fully reporting company. Accelerates Growth Across Energy, Hospitality, and Sustainable Ventures, Driving Scalable Opportunities Worldwide.

LAS VEGAS, May 11, 2026 /PRNewswire/ — Barrel Energy Inc. (OTC: BRLL), an emerging diversified energy company focused on renewable energy and nutritional energy initiatives, today announced that the Company is now a fully reporting company with the U.S. Securities and Exchange Commission (“SEC”), marking a major turning point in the Company’s long term growth strategy and public market development.

Barrel Energy Inc. Announces Full SEC Reporting Status, Strengthening Marketability and positioning for Expansion.

“Our transition to becoming a fully reporting SEC company represents a significant milestone for Barrel Energy and an important step toward increasing the overall marketability and visibility of our stock,” said Jarmin Kaltsas. “We believe today’s market increasingly rewards transparency and compliance, and becoming fully reporting positions us to engage a wider audience of investors, strategic partners, and acquisition opportunities as we continue executing our long term growth strategy under the BRLL trading symbol.”

Management further stated that the Company plans to aggressively pursue growth initiatives intended to expand revenues, strengthen market presence, and enhance shareholder value through strategic business combinations, operational expansion, and scalable energy focused ventures.

About Barrel Energy Inc.

Barrel Energy Inc. (OTC: BRLL) is a diversified energy company focused on opportunities in renewable energy, and nutritional energy initiatives. The Company seeks to leverage strategic acquisitions, public market growth, and innovative energy solutions to create long term shareholder value.

Forward-Looking Statements:

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission.

Barrel Energy – 3859 S. Valley View Blvd, STE 2 #107, Las Vegas, NV, 89103 Tel- 888- 397-9114 Email- info@BRLLenergy.com Social Media-@BRLLenergy all platforms.

View original content:https://www.prnewswire.com/news-releases/barrel-energy-inc-announces-full-sec-reporting-status-strengthening-marketability-and-positioning-company-for-expansion-in-renewable-and-nutritional-energy-markets-302768505.html

SOURCE Barrel Energy, Inc.

Continue Reading

Technology

Legacy Launches $1M Study Advancing At-Home Semen Collection for Assisted Reproduction Technology

Published

on

By

NEW YORK, May 11, 2026 /PRNewswire/ — Legacy, the leading male fertility clinic and at-home sperm testing and cryopreservation platform, today announced the Sperm Study, a clinical research initiative backed by an R&D investment of over $1 million and designed to evaluate and optimize the use of at-home semen collection for assisted reproductive technologies (ART), including IVF and IUI.

Prospectively enrolling up to 250 participants across two phases, this study represents one of the most comprehensive investigations to date into how specimen shipment, handling, and cryopreservation impact sperm quality and is expected to set a new benchmark for scientific rigor in the rapidly growing field of at-home fertility testing. This study is being conducted in collaboration with IVF Academy USA.

Raising the bar for clinical evidence in at-home fertility care

To date, validation work in at-home semen collection has been limited in important ways. Studies have largely enrolled normozoospermic men only, relied on courier-transported rather than real-world-shipped specimens, and focused on short-term motility and concentration as primary endpoints.

Critical questions remain unanswered, particularly around how samples with varying quality perform under genuine end-to-end shipping conditions, and how those samples hold up in the contexts that matter most clinically: IVF and IUI. The Sperm Study is designed to close those gaps.

This multi-phase study will evaluate key sperm quality parameters including motility, DNA fragmentation, and post-thaw viability, while also validating the use of computer-aided semen analysis (CASA) as an alternative to basic manual semen analysis in the setting of mail-in semen analysis.

“With the increased utilization of at-home semen testing and cryopreservation, there is a critical need to ensure these specimens will perform adequately when used for assisted reproduction,” said Legacy’s Chief Medical Officer, Dr. Scott Lundy. “This study is designed to rigorously evaluate how at-home collection and transport impact sperm quality across a broad patient population and to translate those findings into improved protocols and optimized outcomes for both patients and providers.”

Sperm study design and scientific approach

The Sperm Study is a prospectively accruing cross-sectional study in which paired semen samples are analyzed across multiple timepoints and during the shipment process. Importantly, this study enrolls participants across a range of semen quality profiles — not solely normozoospermic men — and evaluates samples under genuine shipping conditions experienced by real specimens.

Key study components include direct comparison of CASA vs. manual analysis at baseline, evaluation of motility decline over time and in relation to shipment conditions, measurement of DNA fragmentation pre- and post-shipment and cryopreservation, assessment of post-thaw sperm viability and yield, and the development of predictive algorithms for IVF/IUI sample sufficiency.

The study will also examine how factors such as transit time, concentration, and storage conditions impact outcomes, with the goal of generating generalizable insights for clinical practice.

Multi-phase rollout

Phase 1 includes 100 participants and approximately 1,500 total assays, with expected completion in 2026. Phase 2, planned for later in 2026 and into 2027, will expand the study with additional participants, bringing the total to up to 250 to enable broader validation across a more diverse patient population.

Impact on clinical practice

Findings from the Sperm Study are expected to directly inform and improve specimen collection protocols for at-home use, shipping and handling standards for semen samples, cryopreservation practices, and clinical decision-making for IVF and IUI readiness.

By generating high-quality, controlled data across a clinically representative patient population, Legacy aims to provide fertility clinics, researchers, and patients with greater confidence in the use of mail-in semen testing and cryopreservation as part of standard reproductive care.

About Legacy

Legacy is the leading male fertility clinic in the United States, offering at-home semen analysis, sperm cryopreservation, and post-vasectomy testing. With a CLIA-certified, high-complexity andrology lab and one of the largest proprietary datasets in male reproductive health, Legacy is advancing access, data, and innovation in fertility care.

View original content to download multimedia:https://www.prnewswire.com/news-releases/legacy-launches-1m-study-advancing-at-home-semen-collection-for-assisted-reproduction-technology-302768508.html

SOURCE Give Legacy, Inc.

Continue Reading

Technology

Elks Award Nearly $5 Million in College Scholarships

Published

on

By

CHICAGO, May 11, 2026 /PRNewswire/ — The Elks National Foundation welcomed 900 students to the Elks family, awarding more than $4.9 million in scholarships to high school seniors. An Elks scholarship is more than financial aid; it’s an invitation to a network of service-minded peers and a promise that an Elks Lodge is always there with open arms.

Out of more than 23,000 applicants for the Most Valuable Student scholarship, the Top 20 scholars received $30,000 scholarships and an invitation to Chicago for the Leadership Weekend.

From April 30-May 3, the Leadership Weekend allowed scholars to get acquainted with their new Elks family through programming facilitated by current and former Elks scholars, team-building activities, and a service opportunity.

“Leadership Weekend is one of my greatest memories,” says Emily Cai, sponsored by Toccoa, Ga., Lodge No. 1820. “I had the privilege of meeting inspirational and disciplined individuals who motivated me to become the best version of myself. I am excited to see my future with the Elks family!”

A total of 480 runners-up received $4,000 Most Valuable Student scholarships.

Service is a tenet of the Elks, which is why it’s a requirement for recipients of the $6,000 Legacy Awards scholarship, which is exclusively for the children or grandchildren of Elks members. The new class of 400 scholars will serve with an Elks Lodge three times during the four years they receive the scholarship.

“This award means a great deal to me and my family,” says Kelly Butler, sponsored by Haverstraw, N.Y., Lodge No. 877. “Knowing that the Elks have invested in my future motivates me to continue working hard and striving toward my goals.”

To see a full list of the scholarship winners and to learn more about the Elks National Foundation’s scholarships, visit elks.org/scholars, follow the ENF on Instagram @ElksScholars, and like the ENF on Facebook @ElksNationalFoundation.

Contact: Elks National Foundation
Abbey Knupp | Manager, Communications
2750 N. Lakeview Ave. | Chicago, IL 60614-2256
773/755-4864 | AbbeyK@elks.org 

Helping Elks Build Stronger Communities

The Elks National Foundation, the charitable arm of the Benevolent and Protective Order of Elks, helps nearly 800,000 Elks and nearly 1,800 Lodges nationwide build stronger communities through programs that support youth, serve veterans, and meet needs in areas where Elks live and work. To learn more, visit elks.org/enf.

View original content to download multimedia:https://www.prnewswire.com/news-releases/elks-award-nearly-5-million-in-college-scholarships-302768507.html

SOURCE ELKS NATIONAL FOUNDATION, INC.

Continue Reading

Trending